HC Wainwright & Co. Maintains Buy on Ekso Bionics Holdings, Raises Price Target to $10

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ekso Bionics Holdings with a Buy and raises the price target from $9.25 to $10.

Analyst UpgradesApr 30 18:43

Earnings Call Summary | Ekso Bionics Holdings, Inc.(EKSO.US) Q1 2024 Earnings Conference

The following is a summary of the Ekso Bionics Holdings, Inc. (EKSO) Q1 2024 Earnings Call Transcript:Financial Performance:Ekso Bionics reported a Q1 2024 revenue of $3.8 million, a slight decrease f

Futu NewsApr 30 08:31 · Conference Call

Ekso Bionics Holdings, Inc. (EKSO) Q1 2024 Earnings Call Transcript

Ekso Bionics Holdings, Inc. (EKSO) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsApr 30 07:39

Ekso Bionics Holdings Q1 2024 GAAP EPS $(0.20) Misses $(0.16) Estimate, Sales $3.756M Miss $4.993M Estimate

Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.16) by 25 percent. This is a 39.39 percent increase over losses of

BenzingaApr 30 04:11

Ekso Bionics Holdings 1Q Rev $3.76M >EKSO

Ekso Bionics Holdings 1Q Rev $3.76M >EKSO

Dow JonesApr 30 04:05

Press Release: Ekso Bionics Announces First Quarter 2024 Financial Results

Ekso Bionics Announces First Quarter 2024 Financial Results SAN RAFAEL, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company" or "Ekso Bionics"), an ind

Dow JonesApr 30 04:05